Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. (Q45363261)
Jump to navigation
Jump to search
scientific article published in October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. |
scientific article published in October 2011 |
Statements
1 reference
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. (English)
1 reference
Jürgen K Rockstroh
1 reference
Michael S Saag
1 reference
Bach-Yen Nguyen
1 reference
STARTMRK Investigators
1 reference
Hedy Teppler
1 reference
Edwin Dejesus
1 reference
Jeffrey L Lennox
1 reference
Hong Wan
1 reference
Monica L Walker
1 reference
Xia Xu
1 reference
Jing Zhao
1 reference
Mark J Dinubile
1 reference
Anthony J Rodgers
1 reference
Randi Leavitt
1 reference
Peter Sklar
1 reference
1 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference